PROTAGONIST THERAPEUTICS INC

Ticker: PTGX CUSIP: 74366E102 Class: Common Stock

KENNEDY CAPITAL MANAGEMENT LLC's Holding History (CIK: 0000884589)

Note: Option positions (PUT/CALL) are excluded.

Q4 2025
Shares 221,444 Value ($000) $19,341 Avg Close $81.85 Range $62.24 - $96.54
Q3 2025
Shares 208,437 Value ($000) $13,846 Avg Close $56.84 Range $49.38 - $68.26
Q2 2025
Shares 134,890 Value ($000) $7,455 Avg Close $47.99 Range $39.60 - $57.70
Q1 2025
Shares 137,504 Value ($000) $6,650 Avg Close $41.90 Range $33.70 - $60.60
Q4 2024
Shares 321,526 Value ($000) $12,411 Avg Close $43.60 Range $33.31 - $48.89
Q3 2024
Shares 267,033 Value ($000) $12,016 Avg Close $40.40 Range $32.50 - $48.00
Q2 2024
Shares 290,082 Value ($000) $10,051 Avg Close $29.29 Range $24.22 - $35.96
Q1 2024
Shares 298,068 Value ($000) $8,623 Avg Close $27.21 Range $21.43 - $33.34
Q4 2023
Shares 304,790 Value ($000) $6,989 Avg Close $17.50 Range $13.72 - $23.88
Q3 2023
Shares 319,534 Value ($000) $5,330 Avg Close $19.40 Range $16.33 - $26.81
Q2 2023
Shares 403,648 Value ($000) $11,149 Avg Close $25.03 Range $17.64 - $30.10
Q1 2023
Shares 331,282 Value ($000) $7,619 Avg Close $16.79 Range $10.62 - $25.69
Q4 2022
Shares 350,133 Value ($000) $3,820 Avg Close $8.44 Range $7.24 - $11.46
Q3 2022
Shares 99,087 Value ($000) $835 Avg Close $9.46 Range $7.68 - $11.97
Q2 2022
Shares 99,176 Value ($000) $784 Avg Close $12.09 Range $6.91 - $25.76
Q1 2022
Shares 97,265 Value ($000) $2,303 Avg Close $28.17 Range $22.56 - $37.05
Q4 2021
Shares 105,394 Value ($000) $3,604 Avg Close $31.61 Range $17.26 - $38.11
Q3 2021
Shares 112,265 Value ($000) $1,989 Avg Close $42.63 Range $12.80 - $50.54
Q2 2021
Shares 71,947 Value ($000) $3,229 Avg Close $33.01 Range $24.14 - $45.93
Q1 2021
Shares 75,518 Value ($000) $1,956 Avg Close $25.31 Range $18.82 - $32.10